CD8A and central nervous system cancer: Saha et al., showed that the triple combination of an OV expressing IL-12 with two immune checkpoint inhibitors targeting PD1 and CTLA-4, can eradicate glioma in two mouse models (204), reducing Tregs, increasing CD8+ T cells and inducing M1-like polarization in TAMs.